C. Starnes

发表

Specific enhancement of the therapeutic effect of anti-idiotype antibodies on a murine B cell lymphoma by IL-2.

R. Levy, N. Berinstein, C. Starnes, 1988, Journal of immunology.

Sesquiterpene antitumor agents: inhibitors of cellular metabolism.

T. G. Waddell, K. Lee, K. Lee, 1977, Science.

C. Starnes, 1992, Nature.

Effects of Palifermin on Antitumor Activity of Chemotherapeutic and Biological Agents in Human Head and Neck and Colorectal Carcinoma Xenograft Models

R. Radinsky, R. Brake, John Lu, 2008, Molecular Cancer Research.

Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Normalization of the nu/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia.

D. Danilenko, G. Pierce, C. Starnes, 1995, The American journal of pathology.

Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors.

A. Coxon, D. Whittington, A. Tasker, 2008, Journal of medicinal chemistry.

Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancer

Daniel J. Freeman, Sameer Doshi, R. Radinsky, 2012, Molecular Cancer.

The effect of AMG 706, a novel multi-kinase inhibitor, on vascular permeability and blood flow as assessed by dynamic contrast enhanced magnetic resonance imaging in an in vivo preclinical tumor model

E. Jackson, A. Coxon, J. Bankson, 2005 .

Cinacalcet attenuates hypercalcemia observed in mice bearing either Rice H-500 Leydig cell or C26-DCT colon tumors.

David A. Martin, C. Henley, S. Scully, 2013, European journal of pharmacology.

Keratinocyte growth factor causes cystic dilation of the mammary glands of mice. Interactions of keratinocyte growth factor, estrogen, and progesterone in vivo.

G. Pierce, J. Tarpley, S. L. Aukerman, 1994, The American journal of pathology.

The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.

P. Kostenuik, S. Morony, C. Capparelli, 2005, Endocrinology.

Anti-inflammatory activity of amine cyanoboranes, amine carboxyboranes, and related compounds.

A. McPhail, I. Hall, C. Starnes, 1980, Journal of pharmaceutical sciences.

Mode of action of sesquiterpene lactones as anti-inflammatory agents.

T. G. Waddell, K. Lee, I. Hall, 1980, Journal of pharmaceutical sciences.

The RANKL Inhibitor Osteoprotegerin (OPG) Causes Greater Suppression of Bone Resorption and Hypercalcemia Compared to Bisphosphonates in Two Models of Humoral Hypercalcemia of Malignancy

P. Kostenuik, S. Morony, C. Capparelli, 2005 .

Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation.

Ling Wang, Kelly Regal, Sesha Neervannan, 2008, Journal of medicinal chemistry.

Phosphatidylinositol-3 Kinase Delta (PI3Kδ) Inhibitor AMG 319 Is a Potent, Selective and Orally Bioavailable Small Molecule Inhibitor That Suppresses PI3K-Mediated Signaling and Viability in Neoplastic B Cells

D. Metz, I. Archibeque, R. Brake, 2011 .

Causes Cystic Dilation of the Mammary Glands of Mice

G. Pierce, J. Tarpley, S. L. Aukerman, 2007 .

COLEYʼS TOXINS, TUMOR NECROSIS FACTOR, AND CANCER RESEARCH—A HISTORICAL PERSPECTIVE

C. Starnes, 1993 .

Antitumor agents. 21. A proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones.

T. G. Waddell, K. Lee, I. Hall, 1977, Journal of medicinal chemistry.

Boron betaine analogs: antitumor activity and effects on Ehrlich ascites tumor cell metabolism.

I. Hall, C. Starnes, P. Wisian-Neilson, 1979, Journal of pharmaceutical sciences.

Antitumor agents XXX: Evaluation of α-methylene-γ-lactone-containing agents for inhibition of tumor growth, respiration, and nucleic acid synthesis

K. Lee, M. Haruna, I. Hall, 1978 .

Anti-inflammatory activity of sesquiterpene lactones and related compounds.

T. G. Waddell, K. Lee, I. Hall, 1979, Journal of pharmaceutical sciences.

Antihyperlipidemic activity of sesquiterpene lactones and related compounds.

T. G. Waddell, K. Lee, I. Hall, 1980, Journal of pharmaceutical sciences.

SESQUITERPENE ANTITUMOR AGENTS- INHIBITORS OF CELLULAR METABOLISM

T. G. Waddell, K. Lee, I. Hall, 1977 .

Coley's toxins, tumor necrosis factor and cancer research: a historical perspective.

C. Starnes, B. Wiemann, 1994, Pharmacology & therapeutics.

Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality.

D. Lacey, K. Rex, C. Potten, 1998, Cancer research.

Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy.

P. Kostenuik, S. Morony, D. Lacey, 2000, Cancer research.

Alternative V kappa gene rearrangements in a murine B cell lymphoma. An explantation for idiotypic heterogeneity

S. Levy, W. Carroll, C. Starnes, 1988, The Journal of experimental medicine.

AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts.

Ling Wang, Sesha Neervannan, Richard Kendall, 2006, Cancer research.

Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non–small-cell lung cancer xenograft models

A. Coxon, A. Polverino, S. Kaufman, 2012, Molecular Cancer.

Discovery of N-phenyl nicotinamides as potent inhibitors of Kdr.

A. Coxon, T. Harvey, R. Syed, 2007, Bioorganic & medicinal chemistry letters.

Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family.

T. Boone, Jane Guo, G. Senaldi, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Combined Treatment of Acute EAE in Lewis Rats with TNF-Binding Protein and Interleukin-1 Receptor Antagonist

D. Danilenko, S. Ogenstad, L. Munyakazi, 1998, Experimental Neurology.

Coley's toxins

C. Starnes, 1992, Nature.

Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non–small-cell lung cancer xenograft models

A. Coxon, A. Polverino, Man Xu, 2012, Molecular Cancer.

ALTERNATIVE V K GENE REARRANGEMENTS IN A MURINE B CELL LYMPHOMA An Explanation for Idiotypic Heterogeneity

S. Levy, C. Starnes, R. Levy, 1988 .

Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.

G. Apell, W. Carroll, M. Campbell, 1988, Journal of immunology.

Keratinocyte Growth Factor Protects Mice from Chemotherapy and Radiation-induced Gastrointestinal Injury and Mortality 1

D. Lacey, K. Rex, C. Potten, 1998 .